Sun Pharmaceuticals Industries Ltd is quoting at Rs 586.05, up 2.99% on the day as on 12:44 IST on the NSE. The stock is up 37.25% in last one year as compared to a 11.67% spurt in NIFTY and a 58.09% spurt in the Nifty Pharma.
Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is quoting at Rs 586.05, up 2.99% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.54% on the day, quoting at 13330.05. The Sensex is at 45332.4, up 0.56%. Sun Pharmaceuticals Industries Ltd has risen around 14.88% in last one month.
Meanwhile, Nifty Pharma index of which Sun Pharmaceuticals Industries Ltd is a constituent, has risen around 7.8% in last one month and is currently quoting at 12353.6, up 1.87% on the day. The volume in the stock stood at 135.4 lakh shares today, compared to the daily average of 107.39 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 587.25, up 2.92% on the day. Sun Pharmaceuticals Industries Ltd is up 37.25% in last one year as compared to a 11.67% spurt in NIFTY and a 58.09% spurt in the Nifty Pharma index.
The PE of the stock is 47.36 based on TTM earnings ending September 20.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU